| Q24535105 | Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay |
| Q42115835 | Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines |
| Q33652072 | Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method |
| Q37067960 | Detection of HIV-1 p24 antigen in patients with varying degrees of viremia using an ELISA with a photochemical signal amplification system |
| Q35678689 | Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda |
| Q28552171 | Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial |
| Q36452388 | Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants |
| Q34400923 | Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests |
| Q33259966 | HIV-1 viral load assays for resource-limited settings |
| Q37257571 | HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus |
| Q34438445 | Presence of IgG anti-gp160/120 antibodies confers higher HIV capture capacity to erythrocytes from HIV-positive individuals. |
| Q34498821 | Presence of p24-antigen associated to erythrocyte in HIV-positive individuals even in patients with undetectable plasma viral load |